Skip to main content

Table 1 Sociodemographic, lifestyle, dietary and blood-sampling related characteristics of participants in the study populations

From: Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition

 

European Prospective Investigation into Cancer and Nutrition

Intercept*

Discovery

Replication

Colorectal cancer

Endometrial cancer

 
  

Cases

Controls

Cases

Control

 

(n = 3029)

(n = 1297)

(n = 423)

(n = 423)

(n = 635)

(n = 648)

(n = 17)

Age, mean (SD)

55.5 (8.1)

55.8 (8.2)

55.7 (7.8)

55.8 (7.9)

53.96 (7.9)

53.99 (7.9)

37.5 (9.7)

Sex, n (%)

 Women

964 (31.8)

431 (33.2)

257 (60.8)

253 (59.9)

635 (100)

648 (100)

11 (64.7)

Educational level, n (%)

 University or higher

674 (22.2)

296 (22.8)

62 (14.6)

65 (15.3)

116 (18.2)

92 (14.2)

13 (76.4)

Body mass index (kg/m2), mean (SD)

26.45 (3.7)

26.47 (3.7)

27.1 (4.5)

26.51 (3.6)

28 (5.4)

25.85 (4.2)

34.2 (3.8)

Categories of BMI, n (%)

 Normal weight

1101 (36.3)

467 (36.0)

142 (33.6)

141 (33.3)

210 (33.1)

315 (48.6)

–

 Overweight

1456 (48.1)

619 (47.7)

182 (43.0)

216 (51.0)

226 (35.6)

239 (36.8)

1 (5.8)

 Obese

472 (15.6)

211 (16.3)

99 (23.4)

66 (15.6)

199 (31.3)

94 (14.5)

16 (94.2)

Waist circumference (cm), mean (SD)

90.7 (12.0)

90.4 (12.1)

89.6 (13.3)

87.8 (11.5)

85.7 (12.1)

81.5 (10.5)

102.8 (8.0)

Waist-hip ratio (cm), mean (SD)

0.89 (0.09)

0.89 (0.09)

0.87 (0.09)

0.86 (0.1)

0.81 (0.06)

0.80 (0.06)

0.86 (0.7)

Height (cm), mean (SD)

169.0 (8.8)

168.9 (8.9)

164.3 (9.1)

163.8 (9.4)

160.2 (6.6)

160.2 (6.8)

170.6 (7.9)

Physical activity, n (%)

 Inactive

679 (22.4)

296 (22.8)

133 (31.4)

122 (28.8)

95 (14.9)

86 (13.3)

NA

 Moderately inactive

1026 (33.9)

463 (35.7)

183 (43.2)

175 (41.4)

189 (29.7)

175 (27.0)

NA

 Moderately active

670 (22.1)

278 (21.4)

63 (14.9)

71 (16.8)

18 (2.8)

13 (2.0)

NA

 Active

597 (19.7)

237 (18.3)

44 (10.4)

54 (12.7)

115 (18.1)

126 (19.4)

NA

Smoking status, n (%)

 Never smoker

1224 (40.4)

518 (39.9)

198 (46.8)

222 (52.5)

82 (12.9)

111 (17.1)

NA

 Current smoker

703 (23.2)

299 (23.0)

90 (21.3)

77 (18.2)

417 (65.6)

396 (61.1)

NA

Meat intake (g/d), mean (SD)

86.5 (55.2)

88.9 (59.5)

76.7 (81.7)

77.6 (44.4)

634.7 (378.8)

646.2 (376.4)

NA

Fish intake (g/d), mean (SD)

37.1 (37.2)

35.3 (33.7)

36.3 (32.4)

37.9 (36.5)

523.9 (316.5)

509.0 (312.9)

NA

Fibre intake (g/d), mean (SD)

23.7 (8.1)

23.3 (7.8)

22.9 (7.6)

23.3 (8.0)

  

NA

Alcohol intake (g/d), mean (SD)

3.1 (1.3)

3.1 (1.27)

2.9 (1.4)

2.7 (1.3)

3.1 (1.2)

3.1 (1.2)

NA

Energy intake (g/d), mean (SD)

2253 (654.7)

2255 (643.0)

2221 (829.0)

2187 (627.9)

661 (383.9)

667 (380.1)

NA

Fasting status, n (%)

 Non-fasting

1351 (44.6)

601 (46.3)

23 (5.4)

23 (5.4)

99 (15.6)

105 (16.2)

17 (100)

Sub-study, n (%)

 Breast cancer controls

752 (24.8)

332 (25.6)

n/a

n/a

n/a

n/a

n/a

 Kidney cancer controls

346 (11.4)

134 (10.3)

n/a

n/a

n/a

n/a

n/a

 Hepatobiliary cancer controls

151 (4.9)

65 (5.0)

n/a

n/a

n/a

n/a

n/a

 Prostate cancer controls

1780 (58.7)

766 (59.0)

n/a

n/a

n/a

n/a

n/a

  1. *Intercept pilot weight loss intervention. NA, not available; n/a, not applicable